---
schema_version: "secwatch.filing_event.v1"
accession: "0001799191-23-000027"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:34:49.669672+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# The Oncology Institute shareholders elect all nine directors, ratify auditor at 2023 annual meeting

## Summary
- 64,996,623 shares voted (~86.4% of outstanding) at June 15 annual meeting.
- All nine director nominees elected with majority support; three nominees had ~13M votes withheld.
- Ratification of BDO USA as independent auditor for FY 2023 passed with 64.3M for, 444k against.

## SEC filing metadata
- accession: 0001799191-23-000027
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000027/0001799191-23-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000027/toi-20230615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001799191-23-000027
- JSON: https://secwatch.observer/filing/0001799191-23-000027.json
- Plain text: https://secwatch.observer/filing/0001799191-23-000027.txt

## Key facts
- Shareholder Votes
  Oncology Institute, Inc. shareholders approved Election of nine directors at the 2023-06-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Proposal 1: Election of Directors All nine nominated directors were elected to hold office until the Company's 2024 annual meeting of stockholders. The stockholders voted as follows: Nominee Votes For Votes Against Votes Withheld Broker Non-Votes Brad Hively 53,352,627 — 961,581 10,682,415 Richard Barasch 53,577,014 — 737,194 10,682,415 Karen Johnson 53,236,553 — 1,077,655 10,682,415 Mohit Kaushal 41,300,185 — 13,014,023 10,682,415 Anne McGeorge 40,469,060 — 13,845,148 10,682,415 Maeve O’Meara 52,748,849 — 1,565,359 10,682,415 Ravi Sarin 40,412,516 — 13,901,692 10,682,415 Gabriel Ling 53,854,419 — 459,789 10,682,415 Mark Pacala 54,230,930 — 83,278 10,682,415
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000027/0001799191-23-000027-index.htm
- Shareholder Votes
  Oncology Institute, Inc. shareholders approved Ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Proposal 2: Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 64,306,320 444,591 245,712 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000027/0001799191-23-000027-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.